ETFChannel.com
GH Description — Guardant Health Inc

Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.

GH — Key Stats (updated Friday, May 20, 10:34 AM)
Company Name: 
Guardant Health Inc
Website: 
www.guardanthealth.com
Sector: 
Medical Instruments & Supplies
Number of ETFs Holding GH: 
42
Total Market Value Held by ETFs: 
$373,650,727.54
Total Market Capitalization: 
$3,283,000,000
% of Market Cap. Held by ETFs: 
11.38%
ETFs Holding GH
 ETF   GH Weight   GH Amount 
 VTI   0.01%   $100,576,691         
 VB   0.05%   $86,887,440         
 VBK   0.20%   $52,385,702         
 VXF   0.06%   $48,224,971         
 IWP   0.11%   $12,340,829         
 IWF   0.02%   $10,953,561         
 VHT   0.06%   $10,571,716         
 IHF   0.64%   $9,722,286         
 IWR   0.03%   $8,982,992         
 XT   0.27%   $8,533,220         
List of all 42 ETFs holding GH »
GH — News
GH — Price Chart
GH — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree GH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Avg. Broker Rec.

Strong Buy (3.75 out of 4)
62nd percentile
(ranked higher than approx. 62% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com
GH — Performance

ETFs Holding GH | Guardant Health Inc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2022, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.